- Home
- TIL vs BWG Comparison
TIL vs BWG Comparison
Compare TIL & BWG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TIL
- BWG
- Stock Information
- Founded
- TIL 2018
- BWG 2012
- Country
- TIL United States
- BWG United States
- Employees
- TIL N/A
- BWG N/A
- Industry
- TIL Biotechnology: Pharmaceutical Preparations
- BWG Finance/Investors Services
- Sector
- TIL Health Care
- BWG Finance
- Exchange
- TIL Nasdaq
- BWG Nasdaq
- Market Cap
- TIL 171.7M
- BWG 140.2M
- IPO Year
- TIL 2021
- BWG N/A
- Fundamental
- Price
- TIL $15.46
- BWG $7.85
- Analyst Decision
- TIL Buy
- BWG
- Analyst Count
- TIL 5
- BWG 0
- Target Price
- TIL $114.00
- BWG N/A
- AVG Volume (30 Days)
- TIL 78.2K
- BWG 53.8K
- Earning Date
- TIL 05-09-2025
- BWG 01-01-0001
- Dividend Yield
- TIL N/A
- BWG 11.37%
- EPS Growth
- TIL N/A
- BWG N/A
- EPS
- TIL N/A
- BWG N/A
- Revenue
- TIL N/A
- BWG N/A
- Revenue This Year
- TIL N/A
- BWG N/A
- Revenue Next Year
- TIL N/A
- BWG N/A
- P/E Ratio
- TIL N/A
- BWG N/A
- Revenue Growth
- TIL N/A
- BWG N/A
- 52 Week Low
- TIL $9.62
- BWG $6.86
- 52 Week High
- TIL $92.00
- BWG $8.65
- Technical
- Relative Strength Index (RSI)
- TIL 44.19
- BWG 41.77
- Support Level
- TIL $14.96
- BWG $7.46
- Resistance Level
- TIL $18.71
- BWG $7.77
- Average True Range (ATR)
- TIL 1.80
- BWG 0.20
- MACD
- TIL 0.09
- BWG -0.01
- Stochastic Oscillator
- TIL 46.32
- BWG 39.00
About TIL Instil Bio Inc.
Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize FRα, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.
About BWG BrandywineGLOBAL Global Income Opportunities Fund Inc.
BrandywineGLOBAL - Global Income Opportunities Fund Inc is a non-diversified, closed-end management investment company. The primary investment objective is to provide current income. The secondary investment objective is capital appreciation. The Fund seeks to achieve its investment objectives by investing, under normal market conditions, at least 80% of its assets in world-wide fixed-income securities.